相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Bacille Calmette-Guerin Vaccination in Infancy Does Not Protect Against Coronavirus Disease 2019 (COVID-19): Evidence From a Natural Experiment in Sweden
Clement de Chaisemartin et al.
CLINICAL INFECTIOUS DISEASES (2021)
BCG vaccination history associates with decreased SARS-CoV-2 seroprevalence across a diverse cohort of health care workers
Magali Noval Rivas et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
BCG vaccination in health care providers and the protection against COVID-19
Mihai G. Netea et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
Merryn Voysey et al.
LANCET (2021)
Reconcile the debate over protective effects of BCG vaccine against COVID-19
Wei Fu et al.
SCIENTIFIC REPORTS (2021)
Bacillus Calmette-Guerin Overexpressing an Endogenous Stimulator of Interferon Genes Agonist Provides Enhanced Protection Against Pulmonary Tuberculosis
Ruchi Jain Dey et al.
JOURNAL OF INFECTIOUS DISEASES (2020)
Comparative Effectiveness of Intravesical BCG-Tice and BCG-Moreau in Patients With Non-muscle-invasive Bladder Cancer
David D'Andrea et al.
CLINICAL GENITOURINARY CANCER (2020)
Early Vaccination With Bacille Calmette-Guerin-Denmark or BCG-Japan Versus BCG-Russia to Healthy Newborns in Guinea-Bissau: A Randomized Controlled Trial
Frederik Schaltz-Buchholzer et al.
CLINICAL INFECTIOUS DISEASES (2020)
Preparedness and vulnerability of African countries against importations of COVID-19: a modelling study
Marius Gilbert et al.
LANCET (2020)
An interactive web-based dashboard to track COVID-19 in real time
Ensheng Dong et al.
LANCET INFECTIOUS DISEASES (2020)
Prevention of tuberculosis in macaques after intravenous BCG immunization
Patricia A. Darrah et al.
NATURE (2020)
Is BCG vaccination affecting the spread and severity of COVID-19?
Cevdet Ozdemir et al.
ALLERGY (2020)
Risks from Deferring Treatment for Genitourinary Cancers: A Collaborative Review to Aid Triage and Management During the COVID-19 Pandemic
Christopher J. D. Wallis et al.
EUROPEAN UROLOGY (2020)
Adjustments in the Use of Intravesical Instillations of Bacillus Calmette-Guerin for High-risk Non-muscle-invasive Bladder Cancer During the COVID-19 Pandemic
Louis Lenfant et al.
EUROPEAN UROLOGY (2020)
SARS-CoV-2 Rates in BCG-Vaccinated and Unvaccinated Young Adults
Uri Hamiel et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China
Chaomin Wu et al.
JAMA INTERNAL MEDICINE (2020)
Considering BCG vaccination to reduce the impact of COVID-19
Nigel Curtis et al.
LANCET (2020)
BCG Vaccination in Humans Elicits Trained Immunity via the Hematopoietic Progenitor Compartment
Branko Cirovic et al.
CELL HOST & MICROBE (2020)
Mandated Bacillus Calmette-Guerin (BCG) vaccination predicts flattened curves for the spread of COVID-19
Martha K. Berg et al.
SCIENCE ADVANCES (2020)
BCG vaccination early in life does not improve COVID-19 outcome of elderly populations, based on nationally reported data
T. M. Wassenaar et al.
LETTERS IN APPLIED MICROBIOLOGY (2020)
Activate: Randomized Clinical Trial of BCG Vaccination against Infection in the Elderly
Evangelos J. Giamarellos-Bourboulis et al.
CELL (2020)
Trained immunity as a molecular mechanism for BCG immunotherapy in bladder cancer
Jelmer H. van Puffelen et al.
NATURE REVIEWS UROLOGY (2020)
BCG vaccine protection from severe coronavirus disease 2019 (COVID-19)
Luis E. Escobar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
BCG as an adjunct or alternative vaccine to prevent COVID-19?
Chien-Hsiang Weng et al.
JOURNAL OF TRAVEL MEDICINE (2020)
BCG epidemiology supports its protection against COVID-19? A word of caution
Reka Szigeti et al.
PLOS ONE (2020)
Lack of evidence for BCG vaccine protection from severe COVID-19
Cecilia S. Lindestam Arlehamn et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Recombinant BCG overexpressing STING agonist elicits trained immunity and improved antitumor efficacy in non-muscle invasive bladder cancer
A. K. Singh et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2020)
Reserving coronavirus disease 2019 vaccines for global access: cross sectional analysis
Anthony D. So et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
Protection against SARS-CoV-2 by BCG vaccination is not supported by epidemiological analyses
Janine Hensel et al.
SCIENTIFIC REPORTS (2020)
Safety and COVID-19 Symptoms in Individuals Recently Vaccinated with BCG: a Retrospective Cohort Study
Simone J. C. F. M. Moorlag et al.
CELL REPORTS MEDICINE (2020)
Bacille Calmette-Guerin (BCG) vaccination and COVID-19. Scientific brief
[Anonymous]
PEDIATRIA I MEDYCYNA RODZINNA-PAEDIATRICS AND FAMILY MEDICINE (2020)
Outcomes of controlled human malaria infection after BCG vaccination
Jona Walk et al.
NATURE COMMUNICATIONS (2019)
European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ)-2019 Update
Marko Babjuk et al.
EUROPEAN UROLOGY (2019)
Association of BCG Vaccination in Childhood With Subsequent Cancer Diagnoses A 60-Year Follow-up of a Clinical Trial
Nicholas T. Usher et al.
JAMA NETWORK OPEN (2019)
Investigating the STING Pathway to Explain Mechanisms of BCG Failures in Non-Muscle Invasive Bladder Cancer: Prognostic and Therapeutic Implications
Madhuri Koti et al.
BLADDER CANCER (2019)
BCG Educates Hematopoietic Stem Cells to Generate Protective Innate Immunity against Tuberculosis
Eva Kaufmann et al.
CELL (2018)
BCG Vaccination Protects against Experimental Viral Infection in Humans through the Induction of Cytokines Associated with Trained Immunity
Rob J. W. Arts et al.
CELL HOST & MICROBE (2018)
The cGAS-cGAMP-STING pathway connects DNA damage to inflammation, senescence, and cancer
Tuo Li et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2018)
Mechanisms of BCG immunotherapy and its outlook for bladder cancer
Caroline Pettenati et al.
NATURE REVIEWS UROLOGY (2018)
Prevention of M-tuberculosis Infection with H4:IC31 Vaccine or BCG Revaccination
E. Nemes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Determinants of BCG scarification among children in rural Guinea-Bissau: A prospective cohort study
Katarina M. Funch et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2018)
Phase 2b Controlled Trial of M72/AS01E Vaccine to Prevent Tuberculosis
O. Van der Meeren et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Neonatal BCG vaccination and atopic dermatitis before 13 months of age: A randomized clinical trial
L. M. Thostesen et al.
ALLERGY (2018)
Safety and Immunogenicity of the Recombinant Mycobacterium bovis BCG Vaccine VPM1002 in HIV-Unexposed Newborn Infants in South Africa
Andre G. Loxton et al.
CLINICAL AND VACCINE IMMUNOLOGY (2017)
Efficacy of bacillus Calmette-Guerin Strains for Treatment of Nonmuscle Invasive Bladder Cancer: A Systematic Review and Network Meta-Analysis
Brock E. Boehm et al.
JOURNAL OF UROLOGY (2017)
Recombinant BCG Expressing ESX-1 of Mycobacterium marinum Combines Low Virulence with Cytosolic Immune Signaling and Improved TB Protection
Matthias I. Groeschel et al.
CELL REPORTS (2017)
The immunopathology of sepsis and potential therapeutic targets
Tom van der Poll et al.
NATURE REVIEWS IMMUNOLOGY (2017)
Cytokine Panel for Response to Intravesical Therapy (CyPRIT): Nomogram of Changes in Urinary Cytokine Levels Predicts Patient Response to Bacillus Calmette-Guerin
Ashish M. Kamat et al.
EUROPEAN UROLOGY (2016)
EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non-Muscle-invasive Stage Ta-T1 Urothelial Bladder Cancer Patients Treated with 1-3 Years of Maintenance Bacillus Calmette-Guerin
Samantha Cambier et al.
EUROPEAN UROLOGY (2016)
Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guideline
Sam S. Chang et al.
JOURNAL OF UROLOGY (2016)
Duration of BCG protection against tuberculosis and change in effectiveness with time since vaccination in Norway: a retrospective population-based cohort study
Patrick Nguipdop-Djomo et al.
LANCET INFECTIOUS DISEASES (2016)
Trained immunity: A program of innate immune memory in health and disease
Mihai G. Netea et al.
SCIENCE (2016)
The efficacy of BCG TICE and BCG Connaught in a cohort of 2,099 patients with T1G3 non muscle-invasive bladder cancer
J. Alfred Witjes et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2016)
Different effects of BCG strains - A natural experiment evaluating the impact of the Danish and the Russian BCG strains on morbidity and scar formation in Guinea-Bissau
H. Frankel et al.
VACCINE (2016)
Immunometabolic Pathways in BCG-Induced Trained Immunity
Rob J. W. Arts et al.
CELL REPORTS (2016)
Different Strains of Bacillus Calmette-Guerin Vaccine Have Very Different Effects on Tuberculosis and on Unrelated Infections
Frank Shann
CLINICAL INFECTIOUS DISEASES (2015)
Nonspecific (Heterologous) Protection of Neonatal BCG Vaccination Against Hospitalization Due to Respiratory Infection and Sepsis
Maria Jose de Castro et al.
CLINICAL INFECTIOUS DISEASES (2015)
BCG Vaccination Enhances the Immunogenicity of Subsequent Influenza Vaccination in Healthy Volunteers: A Randomized, Placebo-Controlled Pilot Study
Jenneke Leentjens et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Heterologous Immunological Effects of Early BCG Vaccination in Low-Birth-Weight Infants in Guinea-Bissau: A Randomized-controlled Trial
Kristoffer Jarlov Jensen et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
BCG-induced trained immunity in NK cells: Role for non-specific protection to infection
Johanneke Kleinnijenhuis et al.
CLINICAL IMMUNOLOGY (2014)
Protection by BCG Vaccine Against Tuberculosis: A Systematic Review of Randomized Controlled Trials
Punam Mangtani et al.
CLINICAL INFECTIOUS DISEASES (2014)
Bacillus Calmette-Guerin Strain Differences Have an Impact on Clinical Outcome in Bladder Cancer Immunotherapy
Cyrill A. Rentsch et al.
EUROPEAN UROLOGY (2014)
Side Effects of Bacillus Calmette-Guerin (BCG) in the Treatment of Intermediate- and High-risk Ta, T1 Papillary Carcinoma of the Bladder: Results of the EORTC Genito-Urinary Cancers Group Randomised Phase 3 Study Comparing One-third Dose with Full Dose and 1 Year with 3 Years of Maintenance BCG
Maurizio Brausi et al.
EUROPEAN UROLOGY (2014)
Systematic review and meta-analysis of the current evidence on the duration of protection by bacillus Calmette–Guérin vaccination against tuberculosis
I Abubakar et al.
HEALTH TECHNOLOGY ASSESSMENT (2014)
The mechanism of action of BCG therapy for bladder cancer-a current perspective
Gil Redelman-Sidi et al.
NATURE REVIEWS UROLOGY (2014)
mTOR- and HIF-1α-mediated aerobic glycolysis as metabolic basis for trained immunity
Shih-Chin Cheng et al.
SCIENCE (2014)
Disseminated infection due to Mycobacterium bovis after intravesical BCG instillation
Sara Marquez-Batalla et al.
WORLD JOURNAL OF CLINICAL CASES (2014)
Bacillus Calmette-Guerin immunotherapy for genitourinary cancer
Nilay M. Gandhi et al.
BJU INTERNATIONAL (2013)
Maintenance Bacillus Calmette-Guerin Treatment of Non-muscle-invasive Bladder Cancer: A Critical Evaluation of the Evidence
Behfar Ehdaie et al.
EUROPEAN UROLOGY (2013)
Final Results of an EORTC-GU Cancers Group Randomized Study of Maintenance Bacillus Calmette-Guerin in Intermediate- and High-risk Ta, T1 Papillary Carcinoma of the Urinary Bladder: One-third Dose Versus Full Dose and 1 Year Versus 3 Years of Maintenance
Jorg Oddens et al.
EUROPEAN UROLOGY (2013)
BCG immunotherapy for bladder cancer-the effects of substrain differences
Christine Gan et al.
NATURE REVIEWS UROLOGY (2013)
Molecular Analysis of Non-Specific Protection against Murine Malaria Induced by BCG Vaccination
Marcela Parra et al.
PLOS ONE (2013)
Pivotal Roles of cGAS-cGAMP Signaling in Antiviral Defense and Immune Adjuvant Effects
Xiao-Dong Li et al.
SCIENCE (2013)
A small jab - a big effect: nonspecific immunomodulation by vaccines
Christine S. Benn et al.
TRENDS IN IMMUNOLOGY (2013)
The Effect of Fibrin Clot Inhibitors on the Immunomodulatory Efficacy of Bacillus Calmette-Guerin Therapy for Non-muscle-invasive Bladder Cancer
Michael J. Lipsky et al.
UROLOGY (2013)
Comparative Tuberculosis (TB) Prevention Effectiveness in Children of Bacillus Calmette-Guerin (BCG) Vaccines from Different Sources, Kazakhstan
Michael Favorov et al.
PLOS ONE (2012)
SMALL RANDOMIZED TRIAL AMONG LOW-BIRTH-WEIGHT CHILDREN RECEIVING BACILLUS CALMETTE-GUERIN VACCINATION AT FIRST HEALTH CENTER CONTACT
Sofie Biering-Sorensen et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2012)
Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes
Johanneke Kleinnijenhuis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Non-specific and sex-differential effects of vaccinations on child survival in rural western India
Siddhivinayak Hirve et al.
VACCINE (2012)
The influence of BCG vaccine strain on mycobacteria-specific and non-specific immune responses in a prospective cohort of infants in Uganda
Elizabeth J. Anderson et al.
VACCINE (2012)
Trained Immunity: A Memory for Innate Host Defense
Mihai G. Netea et al.
CELL HOST & MICROBE (2011)
Randomized Trial of BCG Vaccination at Birth to Low-Birth-Weight Children: Beneficial Nonspecific Effects in the Neonatal Period?
Peter Aaby et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Pediatric Tuberculosis: Global Overview and Challenges
Soumya Swaminathan et al.
CLINICAL INFECTIOUS DISEASES (2010)
An Individual Patient Data Meta-Analysis of the Long-Term Outcome of Randomised Studies Comparing Intravesical Mitomycin C versus Bacillus Calmette-Guerin for Non-Muscle-Invasive Bladder Cancer
Per-Uno Malmstrom et al.
EUROPEAN UROLOGY (2009)
STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity
Hiroki Ishikawa et al.
NATURE (2009)
Mapping the global use of different BCG vaccine strains
Nicole Ritz et al.
TUBERCULOSIS (2009)
STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling
Hiroki Ishikawa et al.
NATURE (2008)
Genome plasticity of BCG and impact on vaccine efficacy
Roland Brosch et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
The influence of previous exposure to environmental mycobacteria on the interferon-gamma response to bacille Calmette-Guerin vaccination in southern England and northern Malawi
R. E. Weir et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2006)
Can intravesical bacillus Calmette-Guerin reduce recurrence in patients with superficial bladder cancer? A meta-analysis of randomized trials
Rui Fa Han et al.
UROLOGY (2006)
Effect of BCG vaccination on childhood tuberculous meningitis and miliarytuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness
BB Trunz et al.
LANCET (2006)
Evaluation of non-specific effects of infant immunizations on early infant mortality in a southern Indian population
LH Moulton et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2005)
Vaccination technique, PPD reaction and BCG scarring in a cohort of children born in Guinea-Bissau 2000-2002
A Roth et al.
VACCINE (2005)
Intravesical bacille Calmette-Guerin versus mitomycin C in superficial bladder cancer:: Formal meta-analysis of comparative studies on tumor progression
A Böhle et al.
UROLOGY (2004)
Intravesical bacillus Calmette-Guerin is superior to mitomycin C in reducing tumour recurrence in high-risk superficial bladder cancer: a meta-analysis of randomized trials
MD Shelley et al.
BJU INTERNATIONAL (2004)
Low birth weight infants and Calmette-Guerin bacillus vaccination at birth community study from Guinea-Bissau
A Roth et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2004)
Long-term efficacy of BCG vaccine in American Indians and Alaska natives - A 60-year follow-up study
NE Aronson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Maintenance bacillus Calmette-Guerin for TaT1 bladder tumors is not associated with increased toxicity: Results from a European organisation for research and treatment of cancer genito-urinary group phase III trial
APM van der Meijden et al.
EUROPEAN UROLOGY (2003)
Proinflammatory cytokines and sepsis syndrome: not enough, or too much of a good thing?
MG Netea et al.
TRENDS IN IMMUNOLOGY (2003)
Spectrum of Bacille Calmette-Guerin (BCG) infection after intravesical BCG immunotherapy
OY Gonzalez et al.
CLINICAL INFECTIOUS DISEASES (2003)
Intravesical bacillus Calmette-Guerin versus mitomycin C for superficial bladder cancer: A formal meta-analysis of comparative studies on recurrence and toxicity
A Bohle et al.
JOURNAL OF UROLOGY (2003)
Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: A meta-analysis of the published results of randomized clinical trials
RJ Sylvester et al.
JOURNAL OF UROLOGY (2002)
Production of MCP-1 and RANTES in bladder cancer patients after bacillus Calmette-Guerin immunotherapy
M Reale et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2002)
Failure of the Mycobacterium bovis BCG vaccine:: Some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis
L Brandt et al.
INFECTION AND IMMUNITY (2002)
A systematic review of intravesical bacillus Calmette-Guerin plus transurethral resection vs transurethral resection alone in Ta and T1 bladder cancer
MD Shelley et al.
BJU INTERNATIONAL (2001)
Routine vaccinations and child survival: follow up study in Guinea-Bissau, West Africa
I Kristensen et al.
BRITISH MEDICAL JOURNAL (2000)
Simple, practical ways to assess the protective efficacy of a new tuberculosis vaccine
GW Comstock
CLINICAL INFECTIOUS DISEASES (2000)
Maintenance bacillus Calmette-Guerin immunotherapy for recurrent Ta, T1 and carcinoma in situ transitional cell carcinoma of the bladder: A randomized Southwest Oncology Group study
DL Lamm et al.
JOURNAL OF UROLOGY (2000)
分享论文
